These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: [Tumor markers in gynecology. General review]. Author: Briese V, Strache RR. Journal: Zentralbl Gynakol; 1988; 110(5):257-66. PubMed ID: 3287800. Abstract: Carcinoembryonic antigen (CEA) and alpha 1-fetoprotein (AFP) should like to be a part of the diagnostic tool of breast and ovarian cancer. HCG is an established specific tumor marker in the monitoring of trophoblastic tumors. The development of a specific HCG-beta-radioimmunoassay led off the possibility to determine the so called subclinical estimation of the tumor tissue. First clinical steps of tissue polypeptide antigen (TPA), cancer antigen 12-5 (CA-12-5), cancer antigen 15-3 (CA-15-3) and D-Dimer would be of great interest to study the correlation between serum concentrations and tumor mass. The following classification is showing other tumor markers in a general review, too dividing molecules produced from the tumor cell itself, so called tumor derived products, and on the other side tumor associated products accompanying the malignancy.[Abstract] [Full Text] [Related] [New Search]